Eliem Therapeutics Inc (ELYM)
7.87
+0.03
(+0.38%)
USD |
NASDAQ |
May 22, 16:00
7.80
-0.07
(-0.89%)
After-Hours: 20:00
Eliem Therapeutics Total Assets (Quarterly): 109.33M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 109.33M |
| December 31, 2023 | 110.47M |
| September 30, 2023 | 112.74M |
| June 30, 2023 | 116.27M |
| March 31, 2023 | 122.08M |
| December 31, 2022 | 134.99M |
| September 30, 2022 | 140.86M |
| Date | Value |
|---|---|
| June 30, 2022 | 150.10M |
| March 31, 2022 | 162.42M |
| December 31, 2021 | 173.24M |
| September 30, 2021 | 182.25M |
| June 30, 2021 | 107.63M |
| March 31, 2021 | 53.69M |
| December 31, 2020 | 24.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
24.63M
Minimum
Dec 2020
182.25M
Maximum
Sep 2021
121.48M
Average
119.18M
Median
Total Assets (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 373.65M |
| Candel Therapeutics Inc | 31.22M |
| Cyclacel Pharmaceuticals Inc | 6.165M |
| Lipocine Inc | 25.45M |
| GlycoMimetics Inc | 34.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.95M |
| Shareholders Equity (Quarterly) | 106.38M |